The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Author(s)
Bhakar, Asha; Dolen, Gul; Bear, Mark
DownloadBear_The pathophysiology.pdf (1.043Mb)
OPEN_ACCESS_POLICY
Open Access Policy
Creative Commons Attribution-Noncommercial-Share Alike
Terms of use
Metadata
Show full item recordAbstract
Fragile X is the most common known inherited cause of intellectual disability and autism, and it typically results from transcriptional silencing of FMR1 and loss of the encoded protein, FMRP (fragile X mental retardation protein). FMRP is an mRNA-binding protein that functions at many synapses to inhibit local translation stimulated by metabotropic glutamate receptors (mGluRs) 1 and 5. Recent studies on the biology of FMRP and the signaling pathways downstream of mGluR1/5 have yielded deeper insight into how synaptic protein synthesis and plasticity are regulated by experience. This new knowledge has also suggested ways that altered signaling and synaptic function can be corrected in fragile X, and human clinical trials based on this information are under way.
Date issued
2012-04Department
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences; Picower Institute for Learning and MemoryJournal
Annual Review of Neuroscience
Publisher
Annual Reviews
Citation
Bhakar, Asha L., Gül Dölen, and Mark F. Bear. “The Pathophysiology of Fragile X (and What It Teaches Us About Synapses).” Annual Review of Neuroscience 35, no. 1 (July 21, 2012): 417–443.
Version: Author's final manuscript
ISSN
0147-006X
1545-4126